• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情在西班牙连续几波疫情期间对血液透析患者及医护人员的影响

Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel.

作者信息

Mas-Fontao Sebastian, Miranda-Serrano Blanca, Hernán David, López Raúl, Manso Paula, Dapena Fabiola, Sánchez-Tocino Mº Luz, Guerrero Jose, Pereira Mónica, Carneiro Damián, Iglesias Adriana, Piña Lola, Guerrero Elena, San Juan Marta, Ledesma Cristina, González Alicia, Rossignoli Araceli, Pereira Concepción, Burgos Marina, Sacristán Ana Mª, González-Parra Emilio, Arenas María Dolores

机构信息

IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029 Madrid, Spain.

出版信息

J Clin Med. 2023 Jun 28;12(13):4337. doi: 10.3390/jcm12134337.

DOI:10.3390/jcm12134337
PMID:37445372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342980/
Abstract

(1) Background: The impact of SARS-CoV-2 has been variable over the time course of the pandemic and in different populations. The aim was to analyze the impact of COVID-19 infection in a known population of hemodialysis (HD) patients and professionals in Spain at different times of the pandemic. (2) Methods: We conducted an observational, descriptive study with a follow-up from 3 March 2020 to 23 April 2022 (776 days), using in average of 414 professionals and 1381 patients from 18 HD units in Spain. The data from the positive PCR or the rapid antigen detection test (RADT) subject were analyzed and segmented into six periods (waves). (3) Results: Of 703 positive COVID-19 tests, 524 were HD patients (74.5%), and 179 were HD professionals (25.5%). Overall, 38% of staff and 43% of patients were affected. Differences were observed in regard to incidence (21% vs. 13%), mortality (3.5% vs. 0%), and symptomatology between the patients and professionals and throughout the pandemic. (4) Conclusions: COVID-19 severity varied during different pandemic waves, with a greater impact seen in the first wave. HD professionals and patients had similar infection rates, but patients had higher mortality rates. Community transmission was the primary route of infection.

摘要

(1) 背景:在新冠疫情的时间进程中以及不同人群中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的影响存在差异。目的是分析在西班牙已知的血液透析(HD)患者和专业人员群体中,新冠病毒感染在疫情不同时期的影响。(2) 方法:我们进行了一项观察性描述性研究,随访时间从2020年3月3日至2022年4月23日(776天),平均纳入了西班牙18个血液透析单位的414名专业人员和1381名患者。对聚合酶链反应(PCR)阳性或快速抗原检测(RADT)阳性受试者的数据进行分析,并划分为六个时期(波次)。(3) 结果:在703例新冠病毒检测阳性病例中,524例为血液透析患者(74.5%),179例为血液透析专业人员(25.5%)。总体而言,38%的工作人员和43%的患者受到影响。在疫情期间,患者和专业人员在发病率(21%对13%)、死亡率(3.5%对0%)和症状方面存在差异。(4) 结论:在不同的疫情波次中,新冠病毒感染的严重程度有所不同,第一波次的影响更大。血液透析专业人员和患者的感染率相似,但患者的死亡率更高。社区传播是主要的感染途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010d/10342980/36f2a733d5bd/jcm-12-04337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010d/10342980/4e7001332065/jcm-12-04337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010d/10342980/36f2a733d5bd/jcm-12-04337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010d/10342980/4e7001332065/jcm-12-04337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010d/10342980/36f2a733d5bd/jcm-12-04337-g002.jpg

相似文献

1
Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel.新冠疫情在西班牙连续几波疫情期间对血液透析患者及医护人员的影响
J Clin Med. 2023 Jun 28;12(13):4337. doi: 10.3390/jcm12134337.
2
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
3
COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves.六次疫情浪潮期间老年患者的新冠病毒疾病临床特征及转归
J Clin Med. 2022 Nov 17;11(22):6803. doi: 10.3390/jcm11226803.
4
Infection Control Practices in In-Center Hemodialysis Units During Wave 1 of the COVID-19 Pandemic in Ontario, Canada: Research Letter.加拿大安大略省新冠疫情第一波期间中心血液透析单位的感染控制措施:研究信函
Can J Kidney Health Dis. 2023 Jan 12;10:20543581221146033. doi: 10.1177/20543581221146033. eCollection 2023.
5
Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings.大型跨国血液透析队列中新冠病毒病发病率和死亡率的风险预测:对门诊血液透析环境中疫情管理的启示
Clin Kidney J. 2021 Feb 5;14(3):805-813. doi: 10.1093/ckj/sfab037. eCollection 2021 Mar.
6
Pregnancy Outcomes in Women With SARS-CoV-2 Infection During the First and Second Waves of the COVID-19 Pandemic in a Tertiary Care Hospital in Ayodhya, Uttar Pradesh, India: A Comparative Study.印度北方邦阿约提亚一家三级护理医院在新冠疫情第一波和第二波期间感染新冠病毒2型的女性的妊娠结局:一项比较研究
Cureus. 2023 Feb 14;15(2):e34969. doi: 10.7759/cureus.34969. eCollection 2023 Feb.
7
Management of Hemodialysis Patients with Suspected or Confirmed COVID-19 Infection: Perspective from the Spanish Nephrology.疑似或确诊 COVID-19 感染血液透析患者的管理:来自西班牙肾脏病学会的观点。
Kidney360. 2020 Sep 11;1(11):1254-1258. doi: 10.34067/KID.0002602020. eCollection 2020 Nov 25.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.SARS-CoV-2 感染炎症性肠病患者:第一波和第二波大流行期间的比较。
BMC Gastroenterol. 2023 Jul 5;23(1):230. doi: 10.1186/s12876-023-02841-0.
10
Psychological review of hemodialysis patients and kidney transplant recipients during the COVID-19 pandemic.新冠疫情期间血液透析患者和肾移植受者的心理状况综述
World J Clin Cases. 2023 Jun 6;11(16):3780-3790. doi: 10.12998/wjcc.v11.i16.3780.

引用本文的文献

1
The Impact and Evolution of COVID-19 on Liver Transplant Recipients Throughout the Pandemic "Waves" in a Single Center.新冠疫情“各波次”期间,COVID-19对单中心肝移植受者的影响及演变
Viruses. 2025 Feb 16;17(2):273. doi: 10.3390/v17020273.
2
The impact of COVID-19 infection before the vaccination era on the hospitalized patients requiring hemodialysis: a single-center retrospective cohort.COVID-19 感染在疫苗接种时代之前对需要血液透析的住院患者的影响:一项单中心回顾性队列研究。
Ren Fail. 2023;45(2):2251593. doi: 10.1080/0886022X.2023.2251593. Epub 2023 Sep 21.

本文引用的文献

1
Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council.西班牙肾脏病学会理事会关于更新西班牙透析单位预防和隔离 SARS-CoV-2 措施建议的立场文件。
Nefrologia (Engl Ed). 2022 Nov-Dec;42(6):714-721. doi: 10.1016/j.nefroe.2023.03.001. Epub 2023 Mar 6.
2
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study.血液透析患者在接受SARS-CoV-2 mRNA疫苗加强剂量3个月后的抗刺突抗体:前瞻性SENCOVAC研究
Clin Kidney J. 2022 Jul 26;15(10):1856-1864. doi: 10.1093/ckj/sfac169. eCollection 2022 Oct.
3
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry.
疫苗时代接受肾脏替代治疗的COVID-19患者的病情不断演变,但死亡率持续居高不下:西班牙COVID-19肾脏替代治疗登记处
Clin Kidney J. 2022 Jun 3;15(9):1685-1697. doi: 10.1093/ckj/sfac135. eCollection 2022 Sep.
4
Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.奥密克戎亚变种非刺突蛋白中的独特突变:对病毒发病机制和宿主免疫逃逸的潜在影响。
Microb Pathog. 2022 Sep;170:105699. doi: 10.1016/j.micpath.2022.105699. Epub 2022 Aug 6.
5
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres.新冠疫情对西班牙16家血液透析中心血液透析血管通路建立的影响
Clin Kidney J. 2022 Apr 14;15(7):1340-1347. doi: 10.1093/ckj/sfac094. eCollection 2022 Jul.
6
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.奥密克戎变异株的二次感染率、传播和潜伏期以及间隔时间,西班牙。
Emerg Infect Dis. 2022 Jun;28(6):1224-1228. doi: 10.3201/eid2806.220158. Epub 2022 Apr 7.
7
Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变种(B.1.1.529):突变、传染性、传播及疫苗抗性
World J Clin Cases. 2022 Jan 7;10(1):1-11. doi: 10.12998/wjcc.v10.i1.1.
8
The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey.2019冠状病毒病大流行对中心血液透析服务的全球影响:一项国际肾脏病学会-透析结果实践模式研究调查
Kidney Int Rep. 2022 Mar;7(3):397-409. doi: 10.1016/j.ekir.2021.12.011. Epub 2021 Dec 13.
9
Beyond Omicron: what's next for COVID's viral evolution.超越奥密克戎:新冠病毒进化的下一步是什么
Nature. 2021 Dec;600(7888):204-207. doi: 10.1038/d41586-021-03619-8.
10
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.慢性肾脏病患者 COVID-19 疫苗的安全性和即刻体液免疫应答:SENCOVAC 研究。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1868-1878. doi: 10.1093/ndt/gfab313.